Analyst Price Targets — PHR
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| February 4, 2026 12:30 pm | Steven Valiquette | Mizuho Securities | $22.00 | $12.78 | TheFly | Phreesia price target lowered to $22 from $28 at Mizuho |
| January 23, 2026 1:54 pm | — | D.A. Davidson | $30.00 | $15.87 | TheFly | Phreesia price target lowered to $30 from $35 at DA Davidson |
| January 8, 2026 9:26 pm | Stan Berenshteyn | Wells Fargo | $30.00 | $16.90 | TheFly | Phreesia initiated with an Overweight at Wells Fargo |
| January 8, 2026 2:28 pm | — | Truist Financial | $24.00 | $17.06 | TheFly | Phreesia price target lowered to $24 from $29 at Truist |
| December 16, 2025 10:36 am | — | Barclays | $24.00 | $16.70 | TheFly | Phreesia price target lowered to $24 from $26 at Barclays |
| December 10, 2025 5:59 pm | — | Truist Financial | $29.00 | $15.97 | TheFly | Phreesia price target lowered to $29 from $36 at Truist |
| December 10, 2025 1:09 pm | Steven Valiquette | Mizuho Securities | $28.00 | $16.07 | TheFly | Phreesia price target lowered to $28 from $36 at Mizuho |
| December 10, 2025 12:23 pm | — | Robert W. Baird | $25.00 | $15.42 | TheFly | Phreesia price target lowered to $25 from $31 at Baird |
| December 9, 2025 11:53 am | Richard Close | Canaccord Genuity | $33.00 | $20.12 | TheFly | Phreesia price target lowered to $33 from $38 at Canaccord |
| December 8, 2025 9:16 pm | — | Barclays | $26.00 | $20.12 | TheFly | Phreesia initiated with an Overweight at Barclays |
Latest News for PHR
NEW YORK, April 16, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Phreesia, Inc. ("Phreesia" or the "Company") (NYSE: PHR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
NEW YORK, April 16, 2026 (GLOBE NEWSWIRE) -- Investors in Phreesia, Inc. (NYSE: PHR) lost between 29% of their holdings on March 30, 2026, after the Company cut FY 2027 revenue guidance to $510-$520 million -- down from the $545-$559 million range issued just months earlier. Shareholders who lost money on PHR are encouraged to submit their information now to discuss their legal rights.
Phreesia guided FY 2027 revenue at $545-$559 million while internal visibility into key segments was already deteriorating -- shareholders who lost money when the guidance was slashed to $510-$520 million may have legal rights. NEW YORK, April 15, 2026 /PRNewswire/ -- Phreesia (NYSE: PHR) shareholders lost between 29% of their investment in a single session on March 30, 2026, after the Company cut FY 2027 revenue…
Phreesia, Inc. (NYSE: PHR - Get Free Report) insider David Linetsky sold 8,332 shares of Phreesia stock in a transaction that occurred on Friday, April 10th. The stock was sold at an average price of $8.07, for a total value of $67,239.24. Following the completion of the sale, the insider owned 224,056 shares in the company,
Phreesia, Inc. (NYSE: PHR - Get Free Report) General Counsel Allison Hoffman sold 14,483 shares of the company's stock in a transaction on Friday, April 10th. The shares were sold at an average price of $8.07, for a total transaction of $116,877.81. Following the completion of the sale, the general counsel directly owned 163,485 shares in
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for PHR.
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.